# A Study of LY2495655 in Older Participants Undergoing Elective Total Hip Replacement

> **NCT01369511** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 400 (actual)

## Conditions studied

- Muscular Atrophy

## Interventions

- **DRUG:** LY2495655
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01369511
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2018-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01369511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01369511, "A Study of LY2495655 in Older Participants Undergoing Elective Total Hip Replacement". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01369511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*